Felbamate (Marlex Pharmaceuticals Inc)
Welcome to the PulseAid listing for the Felbamate drug offered from Marlex Pharmaceuticals Inc. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Marlex Pharmaceuticals Inc |
| NON-PROPRIETARY NAME: | Felbamate |
| SUBSTANCE NAME: | FELBAMATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-08-01 |
| END MARKETING DATE: | 0000-00-00 |
Felbamate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Felbamate from Marlex Pharmaceuticals Inc |
| LABELER NAME: | Marlex Pharmaceuticals Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 400(mg/1) |
| START MARKETING DATE: | 2015-08-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10135-601_247f89ef-aefa-4eac-bb2c-bc6257880305 |
| PRODUCT NDC: | 10135-601 |
| APPLICATION NUMBER: | ANDA201680 |
Other FELBAMATE Pharmaceutical Manufacturers / Labelers:
